Registered entities
Regulus Therapeutics Inc.
Reg. No. 264738379United States
Regulus Therapeutics Inc
Reg. No. 20228212903United States
REGULUS
Reg. No. 331009928United States
Regulus
Reg. No. 40103251399Latvia
Innovation
39 patent families (21 granted) — focus: Chemistry & metallurgy, Human necessities, Operations & transport; filing pace steady. Cited 10,106 times.
| Year | Filings |
|---|---|
| 2015 | 15 |
| 2016 | 13 |
| 2017 | 13 |
| 2018 | 16 |
| 2019 | 11 |
| 2020 | 12 |
| 2021 | 9 |
| 2022 | 9 |
| 2023 | 6 |
| 2024 | 8 |
| 2025 | 8 |
| 2026 | 5 |
Social engagement
Social engagement: 4.7M social following, 1 post in the last 12 months — below the industry typical range.
Investor mix
10 investors on record; lead investors include Alnylam, Ionis Pharmaceuticals; 1 has since exited.
| Investor type | Count | Share |
|---|---|---|
| Venture capital | 4 | 40% |
| Private equity | 1 | 10% |
| Other / undisclosed | 5 | 50% |